Fulgent Genetics Salute del bilancio
Salute finanziaria criteri di controllo 4/6
Fulgent Genetics ha un patrimonio netto totale di $1.1B e un debito totale di $2.9M, che porta il suo rapporto debito/patrimonio netto a 0.3%. Le sue attività totali e le sue passività totali sono rispettivamente $1.2B e $98.9M.
Informazioni chiave
0.3%
Rapporto debito/patrimonio netto
US$2.91m
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | US$213.07m |
| Patrimonio netto | US$1.13b |
| Totale passività | US$98.87m |
| Totale attività | US$1.23b |
Aggiornamenti recenti sulla salute finanziaria
Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14
Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Recent updates
Fulgent Genetics: An NCAV Pick With Profit And Growth Potential
Sep 25Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst
Sep 09Some Shareholders Feeling Restless Over Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Ratio
Jul 17Fulgent Genetics: Growth Is Returning
Jun 06Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package
May 10Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 07Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?
Mar 01Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
Feb 21Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price
Jan 17Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 09Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital
Apr 19Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)
Jan 15Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates
Nov 16Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching
Oct 27Wait For Fulgent Genetics To Grow Up
Oct 13We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending
Sep 19Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05Fulgent Genetics: Poised To Survive Its Post-Covid Hangover
Jul 26Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement
Jul 21Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency
Jun 04Fulgent Is Putting Its Cash Bonanza To Work
May 15These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Fulgent Genetics: Now The Going Could Get Much Tougher
Apr 10Fulgent Genetics: COVID Bolstered The Underlying Business
Mar 17Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
Feb 27Fulgent Genetics Stock: 35% Off Its Recent Highs - It Is Now A Buy
Feb 09Fulgent Genetics: Sell Volatility
Jan 26Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $326.5M ) di FLGT superano le sue passività a breve termine ( $74.0M ).
Passività a lungo termine: Le attività a breve termine di FLGT ( $326.5M ) superano le sue passività a lungo termine ( $24.9M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: FLGT ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di FLGT è aumentato da 0% a 0.3% negli ultimi 5 anni.
Copertura del debito: Il debito di FLGT è ben coperto dal flusso di cassa operativo ( 377.8% ).
Copertura degli interessi: Dati insufficienti per determinare se i pagamenti degli interessi sul debito di FLGT siano ben coperti dall'EBIT.